NDRA
ENDRA LIFE (NDRA)
NASDAQ
$5.15-$0.03 (-0.52%)
Price as of Jun 23, 2026 7:21 PM EDT
  • $6.6M
    Market Cap
  • 58.41%
    1-Year Change
  • Diagnostics & Research
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 69
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$4.74
$5.29
$5.18
1-Year Range
$3.26
$8.84
$5.18
Latest Close$5.18
Change
+$0.42 (+8.11%)
Volume14,131
Market Cap$6.6M
Shares Outstanding1.3M
P/E (TTM)-0.70
Diluted EPS (TTM)-$7.45
Enterprise Value$6.2M

Information as of 06/22/2026

Company Profile

ENDRA LIFE SCIENCES INC
ENDRA LIFE SCIENCES INC
https://endrainc.com
$6.6M
Market Cap
-$7.3M
Net Income
Sector: Healthcare
Industry: Diagnostics & Research
3600 Green Court, Ann Arbor, MI, United States, 48105-1570
734 335 0468

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Key Executives

  • Alexander Y. Tokman
  • Richard Jacroux
  • Idan Steinberg
  • Scott Sober
  • Jonathan Behr

Current Ownership Distribution

  • Mutual Funds13.9M (49.37%)
  • Institutions13.3M (47.38%)
  • Insiders915,364 (3.25%)
  • Other0 (0.00%)